238 related articles for article (PubMed ID: 30280235)
1. [Biologics and further new drugs for rheumatic diseases since 2000].
Krüger K
Orthopade; 2018 Nov; 47(11):906-911. PubMed ID: 30280235
[TBL] [Abstract][Full Text] [Related]
2. Systemic rheumatic diseases: From biological agents to small molecules.
Sarzi-Puttini P; Ceribelli A; Marotto D; Batticciotto A; Atzeni F
Autoimmun Rev; 2019 Jun; 18(6):583-592. PubMed ID: 30959214
[TBL] [Abstract][Full Text] [Related]
3. [Drug therapy of rheumatoid arthritis: where do biologics and novel synthetic disease-modifying antirheumatic drugs stand today?].
Kaudewitz D; Lorenz HM
Inn Med (Heidelb); 2023 Oct; 64(10):1005-1012. PubMed ID: 37493758
[TBL] [Abstract][Full Text] [Related]
4. [What is certain in the treatment of rheumatoid arthritis?].
Witte T
Internist (Berl); 2018 Dec; 59(12):1249-1254. PubMed ID: 30276426
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis.
Kang EH; Liao KP; Kim SC
Curr Rheumatol Rep; 2018 May; 20(7):42. PubMed ID: 29846814
[TBL] [Abstract][Full Text] [Related]
6. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
[TBL] [Abstract][Full Text] [Related]
7. First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register.
Lie E; Fagerli KM; Mikkelsen K; Rødevand E; Lexberg A; Kalstad S; Uhlig T; Kvien TK
Ann Rheum Dis; 2014 Oct; 73(10):1905-6. PubMed ID: 24989896
[No Abstract] [Full Text] [Related]
8. The approach to precision medicine for the treatment of psoriatic arthritis.
Miyagawa I; Tanaka Y
Immunol Med; 2020 Sep; 43(3):98-102. PubMed ID: 32306849
[TBL] [Abstract][Full Text] [Related]
9. Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors.
Jovani V; Calabuig I; Peral-Garrido ML; Tovar-Sugrañes E; López-González MD; Bernabeu P; Martínez A; Esteve-Vives J; León-Ramírez JM; Moreno-Perez O; Boix V; Gil J; Merino E; Vela P; Andrés M
Ann Rheum Dis; 2022 Jul; 81(7):e131. PubMed ID: 32586922
[No Abstract] [Full Text] [Related]
10. The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases.
Singh JA
BioDrugs; 2023 Sep; 37(5):625-635. PubMed ID: 37351790
[TBL] [Abstract][Full Text] [Related]
11. Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Biggioggero M; Benucci M; Li Gobbi F; Grossi V; Infantino M; Meacci F; Manfredi M; Guiducci S; Bellando-Randone S; Matucci-Cerinic M; Foti R; Di Gangi M; Mosca M; Tani C; Palmieri F; Goletti D;
Semin Arthritis Rheum; 2016 Apr; 45(5):519-32. PubMed ID: 26607440
[TBL] [Abstract][Full Text] [Related]
12. Management of vaccination in rheumatic disease.
Wong PKK; Hanrahan P
Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):720-734. PubMed ID: 31427051
[TBL] [Abstract][Full Text] [Related]
13. Restarting biologics and management of patients with flares of inflammatory rheumatic disorders or psoriasis during active tuberculosis treatment.
Cantini F; Prignano F; Goletti D
J Rheumatol Suppl; 2014 May; 91():78-82. PubMed ID: 24789004
[TBL] [Abstract][Full Text] [Related]
14. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
15. Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?
Yen JH
Biomed Pharmacother; 2006 Dec; 60(10):688-92. PubMed ID: 17049202
[TBL] [Abstract][Full Text] [Related]
16. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
[TBL] [Abstract][Full Text] [Related]
17. Disease-modifying antirheumatic drug therapy for psoriatic arthritis.
Salvarani C; Cantini F; Olivieri I
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S71-5. PubMed ID: 12463452
[TBL] [Abstract][Full Text] [Related]
18. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G
Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593
[TBL] [Abstract][Full Text] [Related]
19. Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.
Frisell T; Baecklund E; Bengtsson K; Di Giuseppe D; Forsblad-d'Elia H; Askling J;
Ann Rheum Dis; 2018 May; 77(5):650-657. PubMed ID: 29237621
[TBL] [Abstract][Full Text] [Related]
20. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
